China enacts rules of devolved health tech penalties regime
This article was originally published in Clinica
Executive Summary
China’s healthcare products regulatory agency, the State Food and Drug Administration (SFDA), has passed legislation detailing the rules for issuing penalties against medtech and pharma firms for misconduct.